# Mycobacterium fortuitum: A Neglected Cause of Culture-Negative Prosthetic Valve Endocarditis and a Literature Review

**Authors:** Selen Şahin, İrem Tümkaya Kılınç, Eda Yüksel, Çağla Mehmet, Bedia Dinç, Emine Alp Meşe

PMC · DOI: 10.3390/idr18020023 · 2026-03-13

## TL;DR

This paper reports a rare case of prosthetic valve endocarditis caused by Mycobacterium fortuitum, which was diagnosed only after prolonged incubation and molecular testing.

## Contribution

The paper presents a novel clinical case highlighting the importance of prolonged incubation for diagnosing M. fortuitum endocarditis.

## Key findings

- M. fortuitum was identified after routine blood cultures were negative, requiring extended mycobacterial cultures.
- The patient improved with an amikacin-based combination therapy.
- Prolonged incubation and targeted microbiological workflows are critical for diagnosing culture-negative endocarditis.

## Abstract

Background/Objectives: Prosthetic valve endocarditis caused by non-tuberculous mycobacteria is a rare but serious condition and is often associated with delayed diagnosis due to initially negative routine blood cultures with late positivity after prolonged incubation. Mycobacterium fortuitum, a rapidly growing mycobacterium, is an uncommon cause of endocarditis but may result in significant morbidity if not promptly identified. Methods: We report a 67-year-old man with prior cardiac surgery who presented 18 months later with recurrent fever, weight loss, and renal dysfunction. Initial blood cultures, echocardiography, and standard imaging were non-diagnostic. Ongoing clinical suspicion prompted extended mycobacterial cultures with prolonged incubation and molecular identification performed at a reference laboratory, which revealed M. fortuitum. Results: Antimicrobial susceptibility testing demonstrated susceptibility to amikacin, ciprofloxacin, and clarithromycin, and treatment was initiated with an amikacin-based combination regimen. The patient showed marked clinical and laboratory improvement, including resolution of fever and stabilization of renal function. Conclusions: This case highlights the diagnostic and therapeutic challenges of M. fortuitum prosthetic valve endocarditis and underscores the limitations of routine diagnostic methods in culture-negative endocarditis. It also emphasizes the importance of prolonged incubation and targeted microbiological workflows in suspected cases.

## Linked entities

- **Chemicals:** amikacin (PubChem CID 37768), ciprofloxacin (PubChem CID 2764), clarithromycin (PubChem CID 84029)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, UROD (uroporphyrinogen decarboxylase) [NCBI Gene 7389] {aka PCT, UPD}
- **Diseases:** infection (MESH:D007239), injury to (MESH:D014947), ischemic stroke (MESH:D002544), mycobacterial (MESH:C564468), postoperative infections (MESH:D013530), deterioration of renal function (MESH:D058186), coagulase-negative (MESH:D064726), weight loss (MESH:D015431), renal dysfunction (MESH:D007674), bacteremia (MESH:D016470), embolization (MESH:D004617), cardiovascular infections (MESH:D053821), IE (MESH:D004696), Mycobacterium fortuitum complex (MESH:D009164), fatigue (MESH:D005221), fever (MESH:D005334), wound infections (MESH:D014946), infectious (MESH:D003141), congestive heart failure (MESH:D006333), soft tissue infections (MESH:D018461), inflammation (MESH:D007249), M. fortuitum endocarditis (MESH:C566367), febrile (MESH:D000071072), skin (MESH:D012871), NTM (MESH:D009165), chronic kidney disease (MESH:D051436), cardiac valve involvement (MESH:D006349)
- **Chemicals:** creatinine (MESH:D003404), macrolide (MESH:D018942), Lowenstein (-), doxycycline (MESH:D004318), meropenem (MESH:D000077731), clarithromycin (MESH:D017291), ciprofloxacin (MESH:D002939), Amikacin (MESH:D000583), daptomycin (MESH:D017576), fluoroquinolones (MESH:D024841), linezolid (MESH:D000069349), moxifloxacin (MESH:D000077266)
- **Species:** Mycobacterium (genus) [taxon 1763], Mycolicibacterium fortuitum (species) [taxon 1766], Staphylococcus aureus (species) [taxon 1280], Mycolicibacterium (Mycobacterium fortuitum complex, genus) [taxon 1866885], Candida [taxon 1535326], Homo sapiens (human, species) [taxon 9606], Mycobacteriales (order) [taxon 85007]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC13010777/full.md

---
Source: https://tomesphere.com/paper/PMC13010777